The enrichment of “collagen-containing ECM” and “metallopeptidase activity” suggests BTBD19 may facilitate CRC cell motility and basement membrane degradation, processes essential for metastatic dissemination. This evidence concerns the gene BTBD19 and colorectal carcinoma.